Flolan

Indicated For

Pulmonary Arterial Hypertension

About This Medication

# Flolan Patient Assistance Guide: How to Get Flolan (epoprostenol) at Low or No Cost **Important Update: Flolan (epoprostenol) was discontinued in November 2025 after 30 years on the market.** Patients previously on Flolan have transitioned to alternative therapies like **Veletri (epoprostenol)**, a room-temperature stable version that remains available. This guide focuses on the **GSK Patient Assistance Program (PAP)**, managed by the independent GSK Patient Access Programs Foundation, which may provide eligible GSK medications at no cost. While Flolan is no longer available, the program supports other GSK products, and similar assistance may apply to transitions or related therapies. Always consult your healthcare provider for personalized advice.[7][2][3] ## About Flolan and Pulmonary Arterial Hypertension (PAH) **Flolan (epoprostenol sodium)** is a prostacyclin vasodilator administered via continuous intravenous infusion. It was indicated for treating **pulmonary arterial hypertension (PAH)** (WHO Group I), a condition causing high blood pressure in the lung arteries, to improve exercise capacity, especially in patients with NYHA Functional Class III-IV symptoms.[4] Delivered through a surgically placed catheter and battery-powered pump, Flolan dilated lung blood vessels, increased blood flow, and reduced heart workload—revolutionizing PAH treatment since its 1995 FDA approval.[7] **Key warnings:** Abrupt withdrawal can cause rebound pulmonary hypertension; never stop suddenly. It's contraindicated in heart failure with reduced ejection fraction or hypersensitivity. Monitor for pulmonary edema.[4] Due to discontinuation, patients must switch to alternatives under medical supervision.[7] ## Who Qualifies for GSK Patient Assistance Program? The **GSK PAP** helps uninsured or Medicare patients struggling with costs receive certain GSK medicines at no charge. Eligibility requires:[2][3] - Meeting **financial income criteria** (typically at or below a percentage of the Federal Poverty Level, or FPL; exact thresholds not specified publicly—call for details). - Being **uninsured** or having **Medicare** (with program requirements met). - Living in the **US, Puerto Rico, or US Virgin Islands** (for select medicines). - Treated by a **US-licensed healthcare provider**. **Note:** Since Flolan is discontinued, confirm if the program covers transition support or related products. Visit GSKForYou for eligibility checks.[1][2] ## Income Eligibility Breakdown GSK PAP bases eligibility on household income relative to FPL. While specific Flolan thresholds aren't listed, general PAP guidelines align with common pharma programs (e.g., 400-500% FPL for uninsured/Medicare). Contact GSK at 1-866-728-4368 for your situation.[2] | Household Size | Estimated Max Annual Income (400% FPL, 2026) | Notes | |---------------|----------------------------------------------|-------| | **1 (Individual)** | ~$60,320 | Uninsured or Medicare; verify exact %. | | **2 (Couple)** | ~$81,760 | Add ~$21,440 per additional member. | | **3** | ~$103,200 | Income proof required (tax returns, pay stubs). | | **4** | ~$124,640 | Excludes certain assets; call for precise guidelines. | *Estimates based on 2026 FPL projections; actual program may vary (e.g., <500% FPL). Not guaranteed for discontinued drugs.[2][3]* ## Insurance Requirements - **Uninsured** or **Medicare Part D** patients qualify if income-eligible. - **Private insurance:** May not qualify; explore copay cards via GSKForYou or RxCopays instead.[1][5] - **Medicaid:** Often ineligible, as government programs cover. **Pro tip:** If insured, GSK offers separate copay assistance for commercial plans.[1][5] ## Step-by-Step Application Process 1. **Confirm Eligibility:** Use GSKForYou.com or call 1-866-728-4368. Discuss with your doctor.[1][2] 2. **Gather Documents:** Proof of income (W-2, tax return, pay stubs), proof of residency, prescription, doctor's info.[2] 3. **Get Prescription:** Your US-licensed provider submits or you download forms from gskpaf.org.[2][8] 4. **Apply Online or Mail:** Visit gskpaf.org/gsk/prescription-medicine-patient-assistance or call. HCP portal at gskpro.com.[9] 5. **Submit:** Include all docs; program reviews quickly. 6. **Approval Notification:** Via mail/email/phone. **Phone Support:** 1-866-728-4368 for apps/refills.[2] ## Timeline and Delivery - **Processing:** Typically 2-4 weeks, but urgent cases faster.[2] - **Delivery:** Free medication shipped to your home or doctor's office via specialty pharmacy.[3] - **Refills:** Call 1-866-728-4368 or online; request 30-90 days early to avoid gaps.[2][8] **Critical:** Continuous infusion means no interruptions—plan ahead![4][7] ## Alternatives if Denied or for Discontinued Flolan - **Veletri (epoprostenol):** Biosimilar alternative; room-temp stable, same mechanism. Check manufacturer assistance (Actelion/J&J).[7] - **Other PAH therapies:** Uptravi, Orenitram, Tyvaso (consult doctor). - **GSK Copay Cards:** For insured patients.[5] - **Other PAPs:** NeedyMeds, RxAssist, or PAN Foundation. - **Appeal Denial:** Resubmit with more docs or call for review.[2] ## Disclaimer This guide is for informational purposes only and not medical/financial advice. Eligibility, availability, and terms change; Flolan's discontinuation affects access.[7] Consult your healthcare provider and verify with GSK (gskforyou.com, 1-866-728-4368). GSK PAP excludes vaccines/oncology in refills; managed by independent foundation.[2][3][8] Word count: ~950.

Program information last verified: March 30, 2026